Immunohistochemical validation study of 15-gene biomarker panel predictive of benefit from adjuvant chemotherapy in resected non-small-cell lung cancer: analysis of JBR.10

ObjectiveThere are no validated approaches to predict benefit from adjuvant chemotherapy for resected patients with non-small-cell lung cancer (NSCLC). The aim of this study was to translate a 15-gene mRNA expression profile published by Zhu et al, shown to be prognostic and predictive of benefit, i...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	ESMO open 2020-03, Vol.5 (2), p.e000679, Article e000679
Hauptverfasser:	Grieve, Stacy, Ding, Keyue, Moore, Jonathan, Finniss, Mathew, Ray, Ayush, Lees, Miranda, Hossain, Faisal, Murugesan, Alli, Agar, Jane, Acar, Cenk, Taylor, James, Shepherd, Frances A, Reiman, Tony
Format:	Artikel
Sprache:	eng
Schlagworte:	adjuvant chemotherapy biomarker gene expression profile immunohistochemistry non-small-cell lung cancer Original Research predictive
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!